pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

484 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1554Endpoints1218BioSpace559Fierce Biotech553BioPharma Dive464raps192onclive165fda recalls
therapy area
allOncology10363Rare Disease2700Immunology2440Cardiology2281Hematology1880Pulmonology1872Vaccines
  • Danske Bank corrects website to relocate English PDF to appropriate page
    Danske Bank issued a correction notice indicating that an English PDF document has been moved to the English version of its website. The original announcement had attached both Danish and English…
    globenewswire health · 2mo agoNeutral↗ source
  • Correction: English PDF for Danske Bank transaction disclosures moved to English webpage
    A correction notice has been issued for a Danske Bank disclosure on transactions by persons with managerial responsibilities. The update concerns the location of the English language PDF on the ban…
    globenewswire health · 2mo agoNeutral↗ source
← prev
page 9 of 20
next →
102
fda medwatch93
globenewswire health73
fda press54
1617
Psychiatry & CNS1106
Ophthalmology844
Endocrinology & Metabolism687
Pain654
Nephrology634
Danske Bank corrects placement of English PDF in transaction disclosure
A correction notice was issued for Danske Bank A/S concerning the location of an English PDF file in its public disclosure. The original announcement had both the Danish and English PDFs attached…
globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank corrects webpage to place English PDF in English section
    A correction has been issued for a Danske Bank notification concerning the placement of PDF documents on its website. The original posting attached both the Danish and English versions of the PDF…
    globenewswire health · 2mo agoNeutral↗ source
  • Danske Bank discloses share sales by APMH Invest under its buyback program
    On August 5, 2026, Danske Bank A/S filed a market‑abuse regulation report detailing changes in share ownership among its reporting persons. The filing notes that APMH Invest A/S, a shareholder, so…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports manager share transactions linked to ongoing buy-back program
    Danske Bank A/S filed a notification under the EU Market Abuse Regulation, disclosing transactions made by persons with managerial responsibilities. The filing notes that APMH Invest A/S is contin…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports share sale by APMH Invest under its buyback program
    Danske Bank A/S filed a regulatory disclosure on 5 August 2026 detailing a change in shareholdings linked to its EU‑mandated market‑abuse reporting requirements. APMH Invest A/S sold shares of Dan…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports ongoing share buy-back sales by APMH Invest under regulatory disclosure
    On 5 August 2026 Danske Bank A/S filed a notification under the EU Market Abuse Regulation describing transactions by persons required to report to the Danish FSA and Nasdaq Copenhagen. The bank d…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank corrects website to move English PDF to English page
    Danske Bank issued a correction notice about the placement of its PDF documents on its website. The original posting attached both the Danish and English PDFs under the Danish version of the page.…
    globenewswire health · 2mo agoNeutral↗ source
  • Lilly expands access to its experimental obesity therapy while Jazz pulls Zepzelca's second-line lung cancer use
    Lilly announced it will broaden the expanded‑access program for its obesity drug that has not yet received regulatory approval, allowing more patients to receive the treatment under a compassionate…
    raps · 2mo agoRegulatoryNeutral↗ source
  • FDA invites stakeholder input to shape a new Quantitative Medicine Innovation Network
    The FDA announced it is looking for feedback from a broad range of stakeholders to help design a Quantitative Medicine Innovation Network (QMIN). The proposed QMIN would be a cross-sector platform…
    raps · 2mo agoRegulatoryNeutral↗ source
  • Experts debate extra regulation for low-risk digital wellness devices
    Two recent papers published in JAMA have highlighted concerns about low-risk digital health technologies that consumers use. Experts say that even though these tools are considered low-risk, they…
    raps · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports share sale by APMH Invest under its buyback program
    On August 4, 2026, Danske Bank A/S filed a market‑abuse regulation report detailing a change in share ownership. The filing shows that APMH Invest A/S sold a portion of its Danske Bank shares on a…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank discloses managerial transactions per Danish regulator on Aug 4, 2026
    Danske Bank A/S issued a notification on 4 August 2026 regarding transactions made by individuals who hold managerial responsibilities. The disclosure follows the EU Market Abuse Regulation, requi…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports ongoing share buy-back related sales by APMH Invest
    Danske Bank A/S filed a notification on 4 August 2026 concerning transactions made by persons with managerial responsibilities. The filing, identified as notification no. 61/2026, complies with th…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports ongoing share buy-back and manager-related share sales
    Danske Bank A/S disclosed that, as part of its share repurchase programme, APMH Invest A/S is continuously selling shares on a proportional basis. The filing notes that the transactions are made b…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank files mandatory disclosure of manager transactions under EU market abuse rules
    Danske Bank A/S submitted a notification on 4 August 2026 detailing transactions made by individuals with managerial responsibilities, as required by the Danish Financial Supervisory Authority and…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports share sale by APMH Invest under its buyback program
    On August 4, 2026 Danske Bank A/S filed a regulatory disclosure detailing a change in share ownership among its reporting parties, as required by the EU market abuse regulation. The filing states…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank reports changes in shareholdings of senior staff on Aug 4, 2026
    Danske Bank A/S filed a market abuse regulation report on 4 August 2026 that records changes in share ownership by senior employees and persons closely linked to them. The filing, identified as re…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • Danske Bank files EU market-abuse disclosure of senior staff share transactions
    Danske Bank submitted a filing on 4 August 2026 reporting changes in shareholdings by its senior employees in line with the EU market-abuse regulation. The report lists transactions carried out by…
    globenewswire health · 2mo agoRegulatoryNeutral↗ source
  • FDA releases new guidances on adhesive performance and skin irritation studies for transdermal generic drugs
    The U.S. Food and Drug Administration has issued two new guidances that address transdermal or topical delivery systems for generic drugs. One is a final guidance that outlines how to assess adhesi…
    raps · 2mo agoRegulatoryNeutral↗ source
  • TGA seeks industry input on adopting 11 international scientific guidelines in Australia
    The Therapeutic Goods Administration announced it will consider incorporating eleven internationally recognised scientific guidelines into the Australian regulatory framework. The agency has opene…
    raps · 2mo agoRegulatoryNeutral↗ source
  • FDA issues new guidances on adhesive performance and skin irritation testing for generic transdermal drugs
    The U.S. Food and Drug Administration has released two new guidances that address transdermal and topical delivery systems for generic drugs. One guidance, issued as final, focuses on how manufact…
    raps · 2mo agoRegulatoryNeutral↗ source
  • FDA releases new guidances on adhesives and skin irritation testing for transdermal drug products
    The U.S. Food and Drug Administration has issued two new guidances that focus on transdermal and topical delivery systems used for generic medicines. One guidance, finalized, provides recommendati…
    raps · 2mo agoRegulatoryNeutral↗ source
  • Leo International Precision Health AG issues 3.77 million free shares to PC Beteiligungsgesellschaft mbH after capital increase
    Leo International Precision Health AG announced that its shareholder meeting on June 12, 2026 approved a capital increase funded from company reserves. As a result, the company will allocate 3,772…
    globenewswire health · 2mo agoNeutral↗ source